CH199671A - Process for the preparation of a double compound from 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium salicylate. - Google Patents

Process for the preparation of a double compound from 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium salicylate.

Info

Publication number
CH199671A
CH199671A CH199671DA CH199671A CH 199671 A CH199671 A CH 199671A CH 199671D A CH199671D A CH 199671DA CH 199671 A CH199671 A CH 199671A
Authority
CH
Switzerland
Prior art keywords
dimethylisoxazole
carboxylic acid
acid diethylamide
calcium salicylate
double compound
Prior art date
Application number
Other languages
German (de)
Inventor
F Hoffmann- Aktiengesellschaft
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH199671A publication Critical patent/CH199671A/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

  

  Verfahren zur Herstellung einer Doppelverbindung aus     3,5-Dimethylisoaazol-          4-ssarbonsäurediäthylamid    und     Calciumsalieylat.       Es wurde gefunden, dass die als Arznei  mittel wertvollen sekundären     Amide    von       Isoxazolearbonsäuren    (Patent Nr.<B>185280)</B> mit       Calciumsalzen        aromatiscber        Oxysäuren    sowie  mit     Caleiumrhodanid    kristallisierte Doppel  verbindungen zu bilden vermögen.

   Die Be  deutung dieser neuen Doppelverbindungen  besteht vor allem darin, dass die zumeist  flüssigen oder tief schmelzenden sekundären       Amide    der     3,5-Dimethylisoxazol-4-carbonsäure     in feste, beständige Körper übergeführt werden.  Als weiterer Vorteil der neuen Verbindungen  ist hervorzuheben, dass der bittere     bezw.    salzige  Geschmack der Ausgangsstoffe durch die Ver  bindung mit     Caleiumsalzen    herabgesetzt wird,  oft ganz verschwindet.  



  Die Darstellung der neuen Verbindungen  kann durch Zusammenbringen der Kompo  nenten in geeigneten Lösungsmitteln erfolgen.  Dabei kristallisiert die Doppelverbindung  häufig unmittelbar aus, oder sie wird durch    Zusatz anderer Lösungsmittel, in denen sie  schwer löslich ist, ausgefällt. Sie kann auch  durch Abdampfen des Lösungsmittels ge  wonnen werden. Statt das     Caleiumsalz    als  solches zu verwenden, kann dieses auch in  der Lösung, z. B. aus     Calciumcarbonat    und  der Säure, unmittelbar gebildet werden.  



  Gegenstand des vorliegenden Patentes ist  ein Verfahren zur Herstellung einer Doppel  verbindung aus     3,5-Dimethylisoxazol-4-car-          bonsäurediäthylamid    und     Calciumsalicylat,     welches dadurch gekennzeichnet, dass man auf  3,5     -Dimethylisoxazol    -4-     carbonsäurediäthyl-          amid        Caloiumsalieylat    einwirken lässt.  



  Die neue Doppelverbindung aus 3,5     -Di-          methylisoxazol-4-earbonsäurediäthylamid    und       Caleiumsalicylat        krisallisiert    in Prismen. Sie  ist leicht löslich in Alkohol, mässig löslich  in Wasser, schmeckt schwach süsslich und  soll     alä    Arzneimittel verwendet werden.           Beispiel:     196 Teile     3,5-Dimethylisoxazol-4-carbon-          säurediäthylamid    werden mit 2000 Teilen  Wasser und 278 Teilen trockenem     Calcium-          salicylat    auf dein Dampfbad erwärmt, bis  alles gelöst ist.

   Beim Eindampfen kristallisiert  die Doppelverbindung aus einem     Mol        Calcium-          salicylat    und einem     Mol        3,5-Dimethyliaoxazol-          4-carbonsäurediäthylamid    in Prismen aus.



  Process for the preparation of a double compound from 3,5-dimethylisoaazole-4-ssarboxylic acid diethylamide and calcium salylate. It has been found that the secondary amides of isoxazolearboxylic acids (patent no. 185280), which are valuable as medicaments, are able to form double compounds crystallized with calcium salts of aromatic oxyacids and with calcium rhodanide.

   The main importance of these new double compounds is that the mostly liquid or low-melting secondary amides of 3,5-dimethylisoxazole-4-carboxylic acid are converted into solid, stable bodies. Another advantage of the new compounds should be emphasized that the bitter or. The salty taste of the raw materials is reduced by the connection with Caleium salts, often disappears completely.



  The preparation of the new compounds can be done by bringing the components together in suitable solvents. The double compound often crystallizes out immediately, or it is precipitated by adding other solvents in which it is sparingly soluble. It can also be obtained by evaporating the solvent. Instead of using the Caleiumsalz as such, this can also be in the solution, e.g. B. from calcium carbonate and the acid, are formed directly.



  The subject of the present patent is a process for the preparation of a double compound from 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium salicylate, which is characterized in that calcium salicylate is allowed to act on 3,5-dimethylisoxazole-4-carboxylic acid diethyl amide.



  The new double compound of 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium salicylate crystallizes in prisms. It is easily soluble in alcohol, moderately soluble in water, tastes slightly sweet and should be used as a medicine. Example: 196 parts of 3,5-dimethylisoxazole-4-carboxylic acid diethylamide are heated in a steam bath with 2000 parts of water and 278 parts of dry calcium salicylate until everything has dissolved.

   On evaporation, the double compound crystallizes from one mole of calcium salicylate and one mole of 3,5-dimethyliaoxazole-4-carboxylic acid diethylamide in prisms.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung einer Doppel verbindung aus 3,5-Dimethylisoxazol-4-oarbon- säurediäthylamid und Caciumsalicylat, da durch gekennzeichnet, dass man auf 3,5-Di- methyli8oxazol-4-carbonsäurediäthylamid Cal- ciumsalioylat einwirken lässt. Die neue Doppelverbindung aus 3,5-Di- methylisoxazol-4-carbonsäurediäthylamid und Calciumsalicylat kristallisiert in Prismen. PATENT CLAIM: Process for the production of a double compound from 3,5-dimethylisoxazole-4-carbonic acid diethylamide and calcium salicylate, characterized in that calcium salicylate is allowed to act on 3,5-dimethyli8oxazole-4-carboxylic acid diethylamide. The new double compound of 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium salicylate crystallizes in prisms. Sie ist leicht löslich in Alkohol, mässig löslich in Wasser, schmeckt schwach süsslich und soll als Arzneimittel verwendet werden. It is easily soluble in alcohol, moderately soluble in water, tastes slightly sweet and should be used as a medicine.
CH199671D 1935-11-22 1936-09-09 Process for the preparation of a double compound from 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium salicylate. CH199671A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE199671X 1935-11-22
CH190545T 1936-09-09

Publications (1)

Publication Number Publication Date
CH199671A true CH199671A (en) 1938-08-31

Family

ID=25722000

Family Applications (1)

Application Number Title Priority Date Filing Date
CH199671D CH199671A (en) 1935-11-22 1936-09-09 Process for the preparation of a double compound from 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium salicylate.

Country Status (1)

Country Link
CH (1) CH199671A (en)

Similar Documents

Publication Publication Date Title
CH174811A (en) Process for the preparation of tropic acid-2,2-dimethyl-3-diethylaminopropanol ester.
DE762903C (en) Production of polyphosphates
CH199671A (en) Process for the preparation of a double compound from 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium salicylate.
CH199673A (en) Process for the preparation of a double compound from 3,5-dimethylisoxazole-4-carboxylic acid diethylamide and calcium rhodanide.
CH190545A (en) Process for the preparation of a double compound from 3,5-dimethyl-isoxazole-4-carboxylic acid diethylamide and p-oxybenzoic acid calcium.
AT154137B (en) Process for the preparation of double compounds of N.N-disubstituted amides of 3,5-dimethyl-isoxazolearboxylic acid- (4).
CH199672A (en) Process for the preparation of a double compound from 3,5-dimethylisoxazole-4-carboxylic acid dimethylamide and B-oxynaphthoic acid calcium.
DE643761C (en) Process for the preparation of double compounds of secondary amides of 3, 5-dimethylisoxazole-4-carboxylic acid
AT147483B (en) Process for the preparation of compounds of methyl N-methyltetrahydronicotinate.
DE432420C (en) Process for the preparation of N-methylsulphurous acid salts of secondary amines
CH241111A (en) Process for the production of an easily soluble, durable product containing calcium and the gluconic acid residue.
DE398406C (en) Process for the production of aluminum formate solutions
AT64972B (en) Process for the preparation of hexamethylenetetramine salts of α-phenylquinoline-γ-carboxylic acids.
DE594752C (en) Process for the production of water-soluble organic calcium double compounds
DE515851C (en) Process for the complete separation of technically pure rubidium (and cesium) salts from those of the alkalis
DE374097C (en) Process for the production of double compounds from caffeine which are easily soluble in water
DE447352C (en) Process for the preparation of complex antimony compounds
AT149825B (en) Process for the production of alkali or alkaline earth double compounds of dimethylxanthines with organic acids.
AT158301B (en) Process for the production of vitamin B1.
DE733301C (en) Process for the preparation of soluble double compounds of the pyrazolone series
DE588160C (en) Process for the preparation of new calcium compounds
AT120431B (en) Process for the production of double compounds of urea with sodium iodine.
DE544620C (en) Process for the preparation of 2-pyridonalkylsulfonic acids
DE446110C (en) Production of solid tripotassium phosphate
DE818047C (en) Process for the preparation of concentrated neutral solutions of theophylline